4
Changes in Ownership
BIO-TECHNE Corp Filed Acc 0001062993-23-017156
Pres. Diagnostics & Genom acquired 2,100 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kelderman Kim Pres. Diagnostics & Genom | 2023-08-24 | Option exercise | +2,100 | $47.60 | $99,960 | 21,225 | D |
| Derivatives | |||||||
| Kelderman Kim Pres. Diagnostics & Genom | 2023-08-24 | Option exercise · Stock Option (Right to Buy) | −2,100 | 109,536 | D | ||
Loading xslF345X05/form4.xml…